Combe Company Profile
✉ Email this page to a colleague
What is the competitive landscape for COMBE, and what generic and branded alternatives to COMBE drugs are available?
COMBE has four approved drugs.
Drugs and US Patents for Combe
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Combe | VAGISTAT-1 | tioconazole | OINTMENT;VAGINAL | 020676-001 | Feb 11, 1997 | OTC | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | |||||
Combe | LANABIOTIC | bacitracin; polymyxin b sulfate | DISC;TOPICAL | 050598-001 | Sep 22, 1986 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
Combe | LANABIOTIC | bacitracin zinc; lidocaine; neomycin sulfate; polymyxin b sulfate | OINTMENT;TOPICAL | 062499-001 | Jun 3, 1985 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.